Morgan Stanley
CCEL icon

Morgan Stanley’s Cryo-Cell International CCEL Stock Holding History

Morgan Stanley’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13K Hold
601
– – ﹤0.01% 7325
2025
Q4 		$2.07K Buy
601
+1
+0.2% +$4 ﹤0.01% 7236
2025
Q3 		$2.78K Sell
600
-1
-0.2% -$5 ﹤0.01% 7234
2025
Q2 		$3.12K Hold
601
– – ﹤0.01% 7142
2025
Q1 		$3.83K Hold
601
– – ﹤0.01% 7050
2024
Q4 		$4.46K Buy
601
+1
+0.2% +$8 ﹤0.01% 7033
2024
Q3 		$3.82K Sell
600
-1
-0.2% -$7 ﹤0.01% 6984
2024
Q2 		$4.57K Buy
601
+1
+0.2% +$8 ﹤0.01% 6870
2024
Q1 		$4.48K Sell
600
-600
-50% -$3.39K ﹤0.01% 6918
2023
Q4 		$6.9K Buy
1,200
+800
+200% +$4.14K ﹤0.01% 6928
2023
Q3 		$2.1K Hold
400
– – ﹤0.01% 7122
2023
Q2 		$2.43K Hold
400
– – ﹤0.01% 7153
2023
Q1 		$1.21K Sell
400
-400
-50% -$1.54K ﹤0.01% 7324
2022
Q4 		$3.38K Hold
800
– – ﹤0.01% 7248
2022
Q3 		$5K Hold
800
– – ﹤0.01% 7242
2022
Q2 		$5K Buy
800
+400
+100% +$2.56K ﹤0.01% 7392
2022
Q1 		$3K Hold
400
– – ﹤0.01% 7674
2021
Q4 		$5K Sell
400
-300
-43% -$3.74K ﹤0.01% 7633
2021
Q3 		$8K Buy
+700
New +$8.62K ﹤0.01% 7386

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return

Morgan Stanley's CCEL Position: Q1 2026 in Review

Morgan Stanley held its Cryo-Cell International (CCEL) position steady in Q1 2026 at 601 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #7325.

Morgan Stanley first reported a position in CCEL in Q3 2021 and has held it in 19 quarters since. The position peaked at $8K in Q3 2021. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Morgan Stanley held 601 shares of Cryo-Cell International worth $2.13K as of Q1 2026.
  • Morgan Stanley left its Cryo-Cell International share count unchanged in Q1 2026.
  • Cryo-Cell International made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7325 holding.
  • Morgan Stanley first reported a position in Cryo-Cell International in Q3 2021 and has held it in 19 quarters since.
  • Morgan Stanley's Cryo-Cell International position peaked at $8K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.